Immunogenicity and smoking-cessation outcomes for a novel nicotine immunotherapeutic.
Hatsukami DK, Jorenby DE, Gonzales D, Rigotti NA, Glover ED, Oncken CA, Tashkin DP, Reus VI, Akhavain RC, Fahim RE, Kessler PD, Niknian M, Kalnik MW, Rennard SI.
Hatsukami DK, et al. Among authors: rennard si.
Clin Pharmacol Ther. 2011 Mar;89(3):392-9. doi: 10.1038/clpt.2010.317. Epub 2011 Jan 26.
Clin Pharmacol Ther. 2011.
PMID: 21270788
Free PMC article.
Clinical Trial.